Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2009
12/31/2009US20090325990 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
12/31/2009US20090325955 Gyrase inhibitors and uses thereof
12/31/2009US20090325951 Thienyl-and furanyl-isoquinolinones and methods for using them
12/31/2009US20090325935 Gyrase inhibitors and uses thereof
12/31/2009US20090325927 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor
12/31/2009US20090325228 Fungal cell wall synthesis gene
12/31/2009US20090324672 Poly(Ester-Amide) And Poly(Amide) Coatings For Implantable Medical Devices For Controlled Release Of A Protein Or Peptide And A Hydrophobic Drug
12/31/2009US20090324620 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
12/30/2009WO2009158011A1 Alkynyl alcohols as kinase inhibitors
12/30/2009WO2009157418A1 Carboxylic acid compound
12/30/2009EP2138499A1 Method for manufacturing high purity benzazepin derivatives
12/30/2009EP2138496A1 Antitumoral analogs of lamellarins
12/30/2009EP2137192A1 Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
12/30/2009EP2137182A1 Combination of a narcotic and a non-narcotic analgesic
12/30/2009EP1490047B1 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/30/2009CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor
12/30/2009CA2728767A1 Alkynyl alcohols as kinase inhibitors
12/30/2009CA2727340A1 Carboxylic acid compound
12/29/2009USRE41065 Such as (6,7-dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine for treatment of hyperproliferative diseases
12/29/2009US7638625 Crystalline compounds
12/29/2009US7638546 Imidazolyl derivatives
12/29/2009US7638531 use in treating inflammatory diseases, allergic conditions, diabetes, obesity, an obesity-related disorder, metabolic syndrome, a cognition deficit disorder, cardiovascular and central nervous system disorders
12/29/2009US7638530 1-{1-[4-(3-amino-5-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; anticarcinogenic agents
12/29/2009US7638529 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
12/29/2009US7638527 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
12/29/2009CA2563761C Inhibitors of the hiv integrase enzyme
12/29/2009CA2429440C Dehalogeno-compounds
12/29/2009CA2287214C Substituted benzopyran derivatives for the treatment of inflammation
12/24/2009US20090318529 Fermentation product of marine actinomyces strains; antiproliferative agents; anticarcinogenic agents; low molecular weight, high pharmaceutical potency, and selectivity for cancer cells
12/24/2009US20090318475 Novel, Acyclically Substituted Furopyrimidine Derivatives and Use Thereof
12/23/2009WO2009153897A1 Stemonamide synthesis intermediate and pharmaceutical composition for prevention and/or treatment of cancer
12/23/2009EP2134720A1 Heterocyclic spiro-compounds
12/23/2009EP2134681A1 Trans-annular rearrangement of active lactames
12/23/2009EP1483251B1 C3-cyano epothilone derivatives
12/23/2009CN101611025A 5,6-ring annulated indole derivatives and methods of use thereof
12/23/2009CN101611002A 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
12/23/2009CN101607958A Quinazoline compounds
12/23/2009CN100572360C Isoquinoline compound and its salt preparation method and application
12/23/2009CA2727928A1 Inhibitors of janus kinases
12/22/2009US7635712 Salinosporamides and methods for use thereof
12/22/2009US7635695 4-Amino-2-(4-methyl-thiophen-2-yl)thieno[3,2-c]pyridine-7-carboxylic acid amide; 4-amino-2-cyclopent-1-enyl-thieno[3,2-c]pyridine-7-carboxylic acid amide; for therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease
12/22/2009US7635694 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
12/22/2009US7635693 Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof
12/22/2009CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/22/2009CA2474460C Pyridine- and quinoline-derivatives
12/22/2009CA2362381C Amide compounds and medicinal use thereof
12/22/2009CA2345297C Synthetic analogs of ecteinascidin-743
12/22/2009CA2330976C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents
12/17/2009WO2009152200A1 Tricyclic indole derivatives and methods of use thereof
12/17/2009WO2009150318A1 Novel 2-substituted quinoline derivatives, and method for preparing same
12/17/2009US20090312554 Novel Process for the Preparation of Hexacyclic Compounds
12/17/2009US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009US20090312540 Spatially-defined macrocycles incorporating peptide bond surrogates
12/17/2009US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009US20090312357 Rifaximin
12/17/2009CA2727620A1 Tricyclic indole derivatives and methods of use thereof
12/16/2009EP2133340A1 Novel benzazepine derivatives
12/16/2009CN101605795A Tricyclic compound and medical use thereof
12/16/2009CN101605794A Aza-benzofuranyl compounds and methods of use
12/16/2009CN101602767A Preparation method of galanthamine
12/16/2009CN100569778C Rifabutin crystallization technique
12/16/2009CN100569777C Method of liquid membrane separation for extracting alkaloid of Macleaya cordata
12/16/2009CN100569769C Compounds with antibacterial activity
12/15/2009US7632955 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure
12/15/2009US7632946 ethyl 1-(2,4-dimethoxybenzyl)-7-(2-(S)-hydroxymethyl-pyrrolidin-1-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylate; 7-(2-aminomethylpyrrolidin-1-yl)-1-(2,4-dimethoxybenzyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-caboxylic acid; treating quinolone-resistant bacterial infections in a mammal
12/15/2009US7632830 Lactam compounds and pharmaceutical use thereof
12/15/2009CA2502264C N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/10/2009WO2009148654A2 Cephalotaxus esters, methods of synthesis, and uses thereof
12/10/2009WO2009148062A1 Polycyclic compound and organic electroluminescent device using the same
12/10/2009WO2009148016A1 Halogen compound, polycyclic compound and organic electroluminescent element using the polycyclic compound
12/10/2009WO2009148015A1 Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound
12/10/2009WO2009147616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
12/10/2009US20090306396 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
12/10/2009US20090306387 Method of manufacturing of 7-ethyl-10-hydroxycamptothecin
12/10/2009US20090306169 Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors
12/10/2009US20090306134 Muscarinic receptor antagonists
12/10/2009US20090306127 Certain Chemical Entities, Compositions and Methods
12/10/2009US20090306082 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
12/10/2009US20090306041 Inhibitors of Bruton's tyrosine kinase
12/10/2009US20090305433 Water-Soluble Rhodamine Dye Conjugates
12/10/2009US20090305410 Fluorescent compounds
12/10/2009US20090304692 Triazine compounds as pi3 kinase and mtor inhibitors
12/10/2009CA2725616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
12/09/2009EP2129677A1 Heterocyclic cyclopamine analogs and methods of use thereof
12/09/2009EP2129224A1 5,6-dihydro-1h-pyridin-2-one compounds
12/09/2009EP1692140B1 Compositions useful as inhibitors of protein kinases
12/09/2009EP1443933B1 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
12/09/2009CN101600720A Phosphoinositide 3-kinase inhibitor compounds and methods of use
12/09/2009CN101600703A Dispiro tetraoxane compounds
12/09/2009CN101597295A Method for directly extracting camptothecin from mappia foetida
12/09/2009CN100567302C Production of 7-ethyl-camptothecin
12/09/2009CN100567289C 2-(hetero)aryl substituted tetrahydroquinoline derivatives
12/09/2009CA2634513A1 Novel intermediate compounds and processes for their preparation
12/08/2009US7629468 Neuroprotectants, analgesics or anticonvulsants
12/08/2009CA2482311C Furyl compounds
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009CA2388475C Preparation of chiral 1,2,3,4-tetrahydro-6,7-dialkoxy-3-isoquinolinecarboxylic acid and derivatives
12/08/2009CA2374898C Pyrazinyl-piperazine compounds, their use and preparation
12/08/2009CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
12/03/2009WO2009145282A1 Production method for camptothecin derivative
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 298